メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
森山 和広
客員教員
h-index
374
被引用数
10
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1999 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(27)
類似のプロファイル
(6)
フィンガープリント
Kazuhiro Moriyamaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
High Permeability Membrane
100%
AN69
100%
Chamber Structure
50%
Adsorption Kinetics
50%
Blood Type O
50%
Molecular Damage
50%
Ionic Interaction
50%
In Vitro Evaluation
50%
Transpulmonary Thermodilution
50%
Renal Assist Device
50%
Differential Injection
50%
Lung Assist Device
50%
Cold Saline
50%
Protein Removal
50%
Septic Patients
50%
Return Temperature
50%
Blood Differentials
50%
Membrane Lung
50%
CO2 Removal
50%
Continuous Hemodiafiltration
50%
Blood Return
50%
Decreased Cardiac Output
50%
Cytokine Removal
50%
Newborn piglets
50%
Critically Ill Patients
50%
Polymyxin B-immobilized Fiber Column
50%
Working Fluid
50%
Air Chamber
50%
Chamber Design
50%
Prismaflex
33%
Endotoxin Removal
25%
Synthetic Membranes
22%
Dialysis
22%
Pathogen-associated Molecular Patterns
20%
Jugular Vein
18%
Coagulation Status
18%
Thermostat
16%
Fixation Rate
12%
Closed Circuit
12%
Priming Volume
12%
Sepsis-related Organ Failure Assessment Score
12%
Sepsis Mortality
12%
Cytokine-adsorbing Hemofilter
12%
Cytokine Adsorption
12%
Porcine Blood
12%
Cellular Interactions
12%
Dialysate Flow Rate
12%
Three Principles
12%
Effective Diffusion
12%
Filtration Efficiency
12%
Medicine and Dentistry
In Vitro
100%
Blood Purification
62%
Sepsis
59%
Observational Study
50%
Linezolid
50%
Polymyxin
50%
Bilirubin
50%
Disseminated Intravascular Coagulation
50%
Tumor Lysis Syndrome
50%
Endotoxin
50%
Myoglobin
50%
Lactic Acid
50%
Neonatal Infant
50%
Continuous Renal Replacement Therapy
50%
Granulocyte
50%
Hemodiafiltration
44%
Continuous Kidney Replacement Therapy
33%
Poly(methyl Methacrylate)
33%
Superantigen
26%
Cytokine
26%
Glycerol
25%
Blood Clotting
25%
Neutrophil
25%
SOFA Score
25%
Pathogen Associated Molecular Pattern
20%
Polymyxin B
20%
Continuous Hemofiltration
16%
APACHE II
16%
Endocannabinoid
10%
Organ Dysfunction Score
10%
Pathogen Clearance
10%
Pattern Recognition Receptor
10%
Fluid Resuscitation
10%
Dialysis Fluid
8%
Renal Replacement Therapy
8%
Acute Kidney Injury
8%
Adverse Event
8%
Kidney Function
8%
Apheresis
8%
Hemoperfusion
8%
Mortality Rate
8%
Clinical Trial
8%
Lymphocyte
8%
Immune Response
8%
Bilirubin Glucuronide
7%
Buffer
7%
Hemofiltration
7%
Polyacrylonitrile
7%
Drug Bioavailability
7%
Inflammatory Bowel Disease
7%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Adsorption
70%
Piglet
50%
Endotoxin
50%
Tumor Lysis Syndrome
50%
Polymyxin
50%
Burkitt's Lymphoma
50%
Bilirubin
50%
Cytokine
41%
Organ Dysfunction Score
35%
Hemoperfusion
33%
Chemotherapy
30%
Superantigen
26%
Interleukin 6
25%
Pathogen Associated Molecular Pattern
20%
Polymyxin B
20%
Catecholamine
20%
Septic Shock
15%
Experimental Pig
12%
Endocannabinoid
10%
Anuria
10%
Adult Respiratory Distress Syndrome
10%
Poly(methyl Methacrylate)
10%
Severe Renal Impairment
10%
Dialysis Fluid
10%
Adverse Event
8%
Inflammation
8%
Clinical Trial
8%
Mortality Rate
8%
Buffer
7%
Bilirubin Glucuronide
7%
Polyacrylonitrile
7%
Lactate Dehydrogenase
5%
Anticarcinogen
5%
Hyperkalemia
5%
Interleukin 8
5%
Metabolic Acidosis
5%
High Mobility Group B1 Protein
5%
Respiratory Failure
5%
Hyperuricemia
5%
Replacement Therapy
5%
Disseminated Intravascular Clotting
5%
Acute Kidney Failure
5%
